THE SEID is CFS re-branded with more stringent critera, as anyone aware of medico politics predicted would happen. Unfortunately the 'ME' doesn't get a look in.
What we didn't predict was the name 'disease', but that is not accurate for SEID. No biomarkers are used to prove there is a 'disease' behind SEID, thus the argument of mind Vs body will remain (unlike with HIV AIDS).
Dr Bateman, (the apparent 'twitter' cheerleader for IOM) did not sign the letter of the 50 or so ME experts who were prevented from directly helping to redefine ME, but as a FMS expert, Dr Bateman may greatly benefit from the SEID from here on, because SEID, shuns the core symptoms of ME, instead going for a much more 'wide spectrum' disorder of pain and fatigue that encompasses multiple pain and fatigue disorders physicians see in their clinics.
The 2 CORE signs of ME .
1) Brain inflammatory signs.
2) Muscle pain
are EXCLUDED from SEID .
Conversely increasing heterogenous cohorts through accepting practically anyone into the flock including FMS pains, is in. This won't help 'prove' a specific neuroinflammatory ME exists. It will do the exact opposite.
Take home message: SEID is simply elements of CCC CFS, + the name 'disease', to legitimize chronic unexplained fatigue states.
As mentioned by other people, acquired infection onset is NOT REQUIRED (exactly like Fukuda CFS).
Also immune suppression and other immune abnormalities found in ME, are NOT REQUIRED.
This is good news for Chronic Fatigue patients of unknown cause, but bad if you have a specific disease caused by novel agents, ranging from bacteria/viruses/HERV's/Xeno's. Why? Now even harder to prove, than if you had ME/CFS patients being tested for infection. Why? As with CFS, if and when these agents are detected in the future, you will get a mixed bag results in an SEID cohort, and not conclusive evidence any disease is linked to any novel pathogen.
Who benefits from that?
The patients? No.
The ME researchers? No. They won't get the funding, the funding will go to heterogenous SEID.
Precisely what ME advocates were suggesting would happen.
All in all, a great day if you want to study multiple cause chronic fatigue, not involving brain inflammation, and not involving muscle pain. (What Myalgic Encephalomyeltiis 1969 W.H.O is about).
IOM redefining CFS is 'good' in terms of physicians potentially killing less patients in the community, but it doesn't even begin to answer 'ME' at all.
It would appear the only option left now, is for ME researchers, to continue publishing their work under the title Myalgic Encephalomyeltis, as they have no other choice now. If they choose SEID, the heterogenous pooling of SEID patients, will reduce the numbers of specific infectious agents detected, (if a researchers hypothesis is infection X causes ME).
Again, who benefits from that?